Liofen Liquid contains Baclofen 5 mg, a centrally acting skeletal muscle relaxant indicated for the management of spasticity resulting from multiple sclerosis, spinal cord injuries, or other neurological disorders. Baclofen exerts its therapeutic effect by stimulating GABA_B receptors in the central nervous system, leading to inhibition of monosynaptic and polysynaptic reflexes at the spinal level. This results in reduced muscle tone, decreased muscle spasms, and improved mobility. Liofen Liquid is formulated for oral administration, allowing for flexible dosing and ease of use, particularly in patients who have difficulty swallowing tablets. The liquid form facilitates precise dose adjustments tailored to individual patient needs, enhancing treatment adherence and efficacy. Common adverse effects may include drowsiness, dizziness, weakness, and gastrointestinal disturbances; therefore, caution is advised when initiating therapy or adjusting doses. Baclofen should be used under medical supervision, with gradual dose titration to minimize side effects and avoid abrupt withdrawal, which can precipitate severe complications such as seizures or hallucinations. Liofen Liquid is contraindicated in patients with hypersensitivity to baclofen and should be used cautiously in those with renal impairment. Regular monitoring and clinical evaluation are recommended to optimize therapeutic outcomes and ensure patient safety.